SERB receives EU approval for Voraxaze® (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity
Published on: Friday 14 January 2022
Voraxaze® is now authorized for marketing in all members states of the European Union as well as Iceland, Liechtenstein, and Norway. It will be sold in these markets by SERB, which merged with BTG ...
